January 23, 2007: Q3 Financial Results

HIGHLIGHTS:

1. Q3 Income up 33% (YoY).

2. Q3 Net Profit has increased by 12 times (YoY).

3. Nine months Income up 21% (YoY).

4. Nine months Net Profit up 106% (YoY).

Q3 FINANCIAL RESULTS

The net total income for the 3rd Quarter has gone up by 33% to Rs.233.05 crores as against Rs.174.59 crores in the same period previous financial year. Export Sales have increased by 36% to Rs.124.07 crores.

The Net Profit for the 3rd Quarter has increased by 12 folds to Rs.34.84 crores as against Rs.2.67 crores in the same period of previous year.

3rdQuarter at a glance
(Rs. Crores)
3rd Quarter ended	31.12.2006	31.12.2005	Growth
Net Total Income	233.05	174.59	33%
Export Income	124.07	91.26	36%
Net Profit	34.84	2.67	1205%
Diluted Earnings per share (Rs.)	13.90	1.07	1200%

9 months at a glance
(Rs. Crores)
9 months ended	31.12.2006	31.12.2005	Growth
Net Total Income	699.71	578.94	21%
Export Income	340.11	287.86	18%
Net Profit	94.58	46.02	106%
Diluted Earnings per share (Rs.)	37.74	18.41	105%

Ipca Laboratories is a backward integrated, fast growing pharmaceutical major, with a strong thrust on exports. Exports to nearly 110 countries, now account for nearly 49% of Company's net total income.

M R Chandurkar
Managing Director

:: Also See ::
Unaudited Financial Results